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9-HODE is an oxidation product of linoleic acid (LA, C18:2), is pro-inflammatory, and is 
a ligand for GPR132 which is involved in atherogenesis. By contrast, 13-HODE is 
protective and acts through PPARgamma. Plasma FABP4 is increased in diabetes and 
coronary artery disease. 9-HODE increases FABP4 expression in macrophages. We 
investigated whether GPR132 is a monocyte activation marker in diabetes, and if it 
mediates the effect of 9-HODE on FABP4. Monocyte populations from 31 type 2 
diabetic patients and controls were studied using FACS. Plasma cytokines were measured 
using bead arrays and ELISA. THP-1 cells were used to investigate regulation of FABP4 
secretion. Diabetic subjects had increased circulating CD14
+
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+
 cells (p<0.01), and also increased GPR132 mRNA 
expression in CD14
+
 monocytes (p < 0.01). Levels of GPR132 expression did not 
correlate with any of the above cell populations, or with increased plasma levels of 
FABP4, sTNF-R, osteoprotegerin, MCP-1, resistin or leptin. FABP4 mRNA expression 
was markedly increased in both THP-1 monocytes and macrophages (differentiated with 
100nM PMA) by 9-HODE and 13-HODE (all p < 0.001). 9-HODE (p < 0.01) and 13-
HODE (p < 0.05) also increased GPR132 expression. The stimulatory effect of HODEs 
was replicated by the PPARgamma agonist rosiglitazone (p<0.001). The PPARgamma 
antagonist T0070907 decreased the effect of all three ligands (p<0.001). Similar effects 
on FABP4 protein secretion were documented (ELISA). LA and alpha-linolenic acid 
(C18:3) were without effect on FABP4 mRNA or protein. GPR132 gene silencing using 
siRNA had no effect on increased FABP4 expression in response to 9-HODE, 13-HODE, 
or rosiglitazone. In conclusion, GPR132 is an independent activation marker for 
monocytes, but does not mediate the increase in FABP4 expression induced by 9-HODE. 
FABP4 secretion is regulated through PPARgamma. Study of the signaling functions of 
fatty acids may lead to new treatments for diabetes and atherosclerosis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
